Immutep IMMP
NASDAQ IMMP
$0.39 0.00 (-1.28%)
At close: Aug 21, 2026 · 4:00 PM EDT

Immutep (IMMP) Depreciation & Amortization (CF) (2015 - 2024)

Immutep's (IMMP) quarterly Depreciation & Amortization (CF) came in at $1.5 million in Q2 2024, up 8.17% YoY from $1.4 million in Q3 2023, and up 8.17% on a QoQ basis from $1.4 million in Q2 2023.

Immutep (IMMP) Depreciation & Amortization (CF) (2015 - 2024) Analysis & Trends

Immutep (IMMP) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1.5 million in Q2 2024.

  • Quarterly Depreciation & Amortization (CF) rose 8.17% year-over-year to $1.5 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 48.04% YoY) and the FY2024 annual result came in at $1.5 million, up 8.17% from the prior year.
  • Depreciation & Amortization (CF) climbed to $1.5 million in Q2 2024, from $1.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.5 million in Q2 2024 to a low of $1.4 million in Q2 2020.
  • A 3-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2020 — Depreciation & Amortization (CF) advanced 3.55% — and 2024, when it climbed 8.17%.
  • Tracing IMMP's Depreciation & Amortization (CF) over 3 years: stood at $1.4 million in 2020, then advanced by 1.1% to $1.4 million in 2023, then increased by 8.17% to $1.5 million in 2024.
  • The last three Depreciation & Amortization (CF) figures came in at $1.5 million (Q2 2024), $1.4 million (Q2 2023), and $1.4 million (Q2 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 40.52 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 191.83 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Immutep 56.46 Mn -8.63 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 1.49 Mn
Jun 30, 2024 1.49 Mn
Jun 30, 2023 1.38 Mn
Jun 30, 2023 1.38 Mn
Jun 30, 2020 1.36 Mn
Jun 30, 2020 1.36 Mn
Jun 30, 2019 1.32 Mn
Jun 30, 2019 1.32 Mn
Jun 30, 2017 1.28 Mn
Jun 30, 2017 1.28 Mn
Jun 30, 2016 1.49 Mn
Jun 30, 2016 1.49 Mn
Jun 30, 2015 1.04 Mn
Jun 30, 2015 1.04 Mn